Adding to the body of data for booster shot effectiveness, a new The Lancet report of over 728,000 people w/ 3 shots vs >728,000 matched controls (2 shots): 93% reduction of Covid hospitalizations thelancet.com/journals/lance…

Upcoming ISCT webinar on November 17 on 'Measuring and Managing Batch Variation in MSC Fabrication' Featuring George Muschler, MD, Pamela Robey, Sowmya Viswanathan, and David Stroncek Read the details and register: isctglobal.org/events/event-d…

If you think Prior Covid protects against Omicron (B.1.1.529), think again medrxiv.org/content/10.110… and "Neutralizing antibody titers against Omicron were low, even below the limit of detection in a significant fraction of convalescent individuals drive.google.com/file/d/1zjJWsy…

On his last day as @NIHDirector, we want to #ThankYouDrCollins for his service. As the longest serving appointed Director, he has steered the country’s largest medical research agency with a calm hand, a scientific mind, & a deep commitment to the well-being of all Americans.

UK had a sharp decoupling between Covid cases and deaths through its recent delta wave, a trend that hopefully continues with omicron. This is a measure of vaccines and population immunity that’s mitigating the most severe impact of new infections, changing how we confront SARS2.

Great 1-slide summary. I find the experimental data convincing that Omicron is substantially less able to infect lung cells.

BNO News Live

Congratulations to Nicolas Piuzzi, MD the ORS Strategies in Clinical Research Section Podium Award Recipient at #ORS2022! Learn more about the Section & Join us at the Scientific meeting in April! ors.org/strategies-cli…

THA PROMs Phenotypes predict Dissatisfaction - #AAOS2022 pubmed.ncbi.nlm.nih.gov/35279339/ #StandWithUkraine️

I am very proud to be inducted as an ⁦⁦AAAS Fellows Soc Sci⁩ this year, and grateful for the many collaborators, colleagues and students who have made our work Cleveland Clinic, @LernerResearchInstitute and beyond possible. linkedin.com/posts/geoff-vi…

Good interview on the status of new musculoskeletal technologies earlier this week. wakr.net/local-news/thi…

The official welcome to ISCT 2023 Paris from our president Jacques Galipeau! “The wind is in our sails” #ISCT2023

#ISCT2023 Presidential Luncheon celebrating contributions of our #celltherapy #genetherapy leaders and successful #Paris Annual Meeting ISCT

pubmed.ncbi.nlm.nih.gov/38122838/ NO utility of requiring PROMs with a minimum follow-up of 2 years for THA and TKA Research efforts should be focused on registries evaluating implant survivorship at longer-term follow-up, while PROMs should be better assessed up to 1-year follow-up

Our team Cleveland Clinic Cleveland Clinic Research is extraordinary proud that the technology that we translated in forming Cell X Technologies is being discovered, and demonstrating valuable inthe cell therapy community, and particularly the remarkable team at Aspen Neuroscience. prnewswire.com/news-releases/…

Join us in New Orleans! #ISCT2025

Join us in New Orleans! #ISCT2025

Join us in New Orleans! #ISCT2025